Belarusian
Albanian
Arabic
Armenian
Azerbaijani
Belarusian
Bengali
Bosnian
Catalan
Czech
Danish
Deutsch
Dutch
English
Estonian
Finnish
Français
Greek
Haitian Creole
Hebrew
Hindi
Hungarian
Icelandic
Indonesian
Irish
Italian
Japanese
Korean
Latvian
Lithuanian
Macedonian
Mongolian
Norwegian
Persian
Polish
Portuguese
Romanian
Russian
Serbian
Slovak
Slovenian
Spanish
Swahili
Swedish
Turkish
Ukrainian
Vietnamese
Български
中文(简体)
中文(繁體)

Transgender, Silicone and Blood Smear

Перакладаць артыкулы могуць толькі зарэгістраваныя карыстальнікі
Увайсці / Зарэгістравацца
Спасылка захоўваецца ў буферы абмену
СтатусЗавершаны
Спонсары
Assistance Publique - Hôpitaux de Paris

Ключавыя словы

Рэферат

This cross-sectional monocentric study will describe transgender men transitioning into women and who had cosmetic silicone injection.
The principal objective is to estimate the prevalence of Transgender with circulating monocytes containing silicone vacuoles in blood smears among Male to Female Transgender population with a history of cosmetic silicon injections.
The secondary objectives are to describe the transgender population, to describe the quantity of silicone in vacuoles of circulating monocytes, and the association between dermatological complications (inflammatory and not inflammatory) and several clinical and biological characteristics (HIV status, level of immunosuppression, inflammatory syndrome, quantity of silicone which was injected , silicone quantity in blood smears).

Апісанне

Injectable liquid silicone is a permanent filling product which is no more used in France because of a high risk of complications. Cosmetic silicone injection is a common feminization approach for transgender populations.

This cross-sectional monocentric study will describe transgender men transitioning into women and who had cosmetic silicone injection.

The principal objective is to estimate the prevalence of Transgender with circulating monocytes containing silicone vacuoles in blood smears among Male to Female Transgender population with a history of cosmetic silicon injections.

The secondary objectives are to describe the transgender population, to describe the quantity of silicone in vacuoles of circulating monocytes, and the association between dermatological complications (inflammatory and not inflammatory) and several clinical and biological characteristics (HIV status, level of immunosuppression, inflammatory syndrome, quantity of silicone which was injected , silicone quantity in blood smears).

Даты

Апошняя праверка: 08/31/2015
Упершыню прадстаўлена: 09/29/2015
Меркаваная колькасць заявак прадстаўлена: 10/17/2015
Першае паведамленне: 10/19/2015
Апошняе абнаўленне адпраўлена: 01/21/2016
Апошняе абнаўленне апублікавана: 01/24/2016
Фактычная дата пачатку даследавання: 06/30/2015
Разліковая дата першаснага завяршэння: 11/30/2015
Разліковая дата завяршэння даследавання: 12/31/2015

Стан альбо хвароба

Injection; Complications, Sepsis
Injection Site Disorder
Injection Site Extravasation
Intentional Poisoning by Silicone

Фаза

-

Групы ўзбраенняў

РукаЎмяшанне / лячэнне
Cosmetic silicone injection
People responding to inclusion criteria with a history of cosmetic silicone injection

Крытэрыі прыдатнасці

Узрост, які мае права на вучобу 18 Years Каб 18 Years
Пол, прыдатны для навучанняMale
Метад адбору пробNon-Probability Sample
Прымае здаровых валанцёраўТак
Крытэрыі

Inclusion Criteria:

- Adults

- Not in opposition to data collection

- Transgender men transitioning into women patients with cosmetic silicone injection

- Consultation in Bichat hospital

Exclusion Criteria:

- Unable to communicate

- Guardianship, curatorship

Вынік

Першасныя вынікі

1. The prevalence of Transgender with circulating monocytes containing silicone vacuoles in blood smear among Male to Female Transgender population, the day of their consultation. [1 day ,the day of their consultation]

The prevalence of Transgender with circulating monocytes containing silicone vacuoles will be calculated as the number of subjects with monocytes containing silicone vacuoles in blood smears on the number of subjects with a history of silicone cosmetic injection

Меры другаснага выніку

1. Number of monocytes with vacuoles of silicone in a standardized area of 25 monocytes per blood smear slide [1 day ,the day of their consultation]

2. Size of silicone vacuoles in monocytes [1 day ,the day of their consultation]

3. Inflammatory and not inflammatory dermatological complications [1 day ,the day of their consultation]

assessment of dermatological complications during the clinical examination

4. Number of patients with a positive HIV status [1 day ,the day of their consultation]

Number of patients with a positive HIV status

5. Level of immunosuppression estimated with viral charge [1 day ,the day of their consultation]

HIV viral load, the day of the admission or the last value known in the 6 month prior to the consultation

6. Level of immunosuppression estimated with cluster of differentiation 4 cell (CD4) rate [1 day ,the day of their consultation]

CD4 cell count the day of the consultation or the last value known in the 6 month prior to the consultation. CD4 cell stands for Cluster of differentiation antigen 4 cell.

7. Inflammatory syndrome estimated with C-reactive protein (CRP) [1 day ,the day of their consultation]

8. Inflammatory syndrome estimated with ferritin [1 day ,the day of their consultation]

9. Amount of injected silicone, in liters [1 day ,the day of their consultation]

10. Time since the first silicone injection for cosmetic purposes, in years [1 day ,the day of their consultation]

11. Comorbidities: Number of patients with history of Tuberculosis [1 day ,the day of their consultation]

Number of patients with history of Tuberculosis

12. Comorbidities: Number of patients with history of Hepatitis B [1 day ,the day of their consultation]

Number of patients with history of Hepatitis B

13. Comorbidities: Number of patients with history of Hepatitis C [1 day ,the day of their consultation]

Number of patients with history of Hepatitis C

14. Comorbidities: Number of patients with history of Syphilis [1 day ,the day of their consultation]

Number of patients with history of Syphilis

Далучайцеся да нашай
старонкі ў facebook

Самая поўная база дадзеных пра лекавыя травы, падтрыманая навукай

  • Працуе на 55 мовах
  • Лячэнне травой пры падтрымцы навукі
  • Распазнаванне траў па малюнку
  • Інтэрактыўная GPS-карта - пазначце травы па месцы (хутка)
  • Чытайце навуковыя публікацыі, звязаныя з вашым пошукам
  • Шукайце лекавыя зёлкі па іх уздзеянні
  • Арганізуйце свае інтарэсы і будзьце ў курсе навінавых даследаванняў, клінічных выпрабаванняў і патэнтаў

Увядзіце сімптом альбо захворванне і прачытайце пра зёлкі, якія могуць дапамагчы, набярыце траву і паглядзіце хваробы і сімптомы, супраць якіх яна выкарыстоўваецца.
* Уся інфармацыя заснавана на апублікаваных навуковых даследаваннях

Google Play badgeApp Store badge